Long-term HIV remission has been achieved in a patient following a stem cell transplant from a sibling carrying a certain genetic mutation, according to research published in Nature Microbiology.

HIV-infected_T_cell_(6813489183)

Source: NIAID

Scanning electromicrograph of an HIV-infected T cell.

HIV can remain hidden in pockets of cells across various tissues in the body even when effective treatment keeps the virus under control, which is why stopping antiretroviral medication normally causes the virus to return.

However, previous cases of remission after stem cell transplantation have highlighted the potential of donor cells containing the CCR5Δ32/Δ32 mutation, which removes a receptor that HIV commonly uses to infect cells.

Case history

Anders Eivind Myhre, Marius Trøseid and colleagues analysed samples from a 63-year-old man, who had been diagnosed with HIV-1 subtype B in 2006 at 44 years of age.

In 2020, he received a stem cell transplant from a sibling with the CCR5Δ32/Δ32 mutation to treat myelodysplastic syndrome, a type of blood cancer.  Antiretroviral therapy was subsequently discontinued 24 months afterwards.

Over time, the donor’s cells were found to replace the patient’s own immune cells in the blood, bone marrow and gut tissues. Analyses of biopsies taken two years after the transplant showed no proviral HIV DNA — viral genetic material that is integrated into the host DNA of infected cells — in blood or gut samples.

Viral absence

When the authors examined more than 65 million CD4⁺ T cells from the patient, they detected no virus capable of multiplying. The patient also had no detectable HIV‑specific T-cell responses, and his HIV antibody levels declined over four years after transplantation, although he remained positive for antibodies against one HIV protein, the Env protein.

The findings suggest that receiving donor cells resistant to HIV, combined with full replacement of immune cells across different parts of the body, may help to reduce or remove HIV reservoirs. However, it is not possible to know how much each factor contributed, and early samples were limited. The authors note that stem cell transplantation is not a practical approach for most people with HIV, but studying these cases can help identify signs that predict long‑term remission and guide future research.

Topics